Table 3 Technical characteristics of plasma exchange therapy 2
From: Efficacy and safety of plasma exchange for Kawasaki disease with coronary artery dilatation
Patient | Total volume of plasma removed (mL) | Plasma separator | Replacement fluid |
|---|---|---|---|
1 | 1415 | Plasma flow OP-05® | FFP |
2 | 5394 | Centrifugation | FFP |
3 | 2692 | Centrifugation | FFP |
4 | 1540 | Plasma flow OP-02® | 5% albumin |
5 | 1515 | Plasma flow OP-02® | FFP, 5% albumin |
6 | 3819 | Plasma flow OP-02® | FFP, 5% albumin |
7 | 2800 | Plasma flow OP-02® | 5% albumin |
8 | 2780 | Plasma flow OP-02® | FFP, 5% albumin |
9 | 600 | Plasma flow OP-02® | FFP |
10 | 3000 | Plasma flow OP-02® | 5% albumin |